Medical Devices
-
Resmed to sell MatrixCare for $490M to private equity firm
Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources to faster-growing parts of its portfolio.
By Susan Kelly • July 8, 2026 -
Top surgical robotics stories in the first half of 2026
The market for robotic surgery got more competitive this year, with Medtronic, Stryker, CMR Surgical and Distalmotion introducing new platforms. Check up on their progress and more in MedTech Dive’s roundup of robotics coverage.
By Susan Kelly • July 8, 2026 -
Explore the Trendlineâž”
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
By Nick Paul Taylor • July 7, 2026 -
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
By Nick Paul Taylor • July 6, 2026 -
Medicare slashes 340B payments, broadens site-neutral policies in proposed 2027 payment rule
The rule, released Thursday, builds on Trump administration priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
By Sydney Halleman • July 6, 2026 -
US blocks quick USMCA extension, putting annual review process into motion
The U.S., Mexico and Canada will continue negotiating about potential adjustments to the trilateral free trade agreement, which will remain in place until at least 2036.
By Phil Neuffer • July 2, 2026 -
Retrieved from Hologic on January 16, 2025
FDA updates Hologic BioZorb recall, citing 252 injuries
While the company no longer manufactures the radiographic markers, healthcare providers are still advised to monitor patients who have had them implanted.
By Susan Kelly • July 1, 2026 -
FDA authorizes more devices so far in 2026, but it’s taking longer
Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.
By Elise Reuter • July 1, 2026 -
Roche takes on Illumina with new NGS system
When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.”
By Susan Kelly • June 30, 2026 -
DePuy Synthes names CFO ahead of J&J split
Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.
By Nick Paul Taylor • June 30, 2026 -
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic
Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
By Susan Kelly • June 29, 2026 -
J&J starts pivotal trials of Shockwave IVL device in carotid arteries
J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.
By Nick Paul Taylor • June 29, 2026 -
Aidoc wins breakthrough nod for AI that reads chest X-rays
Aidoc is working on an artificial intelligence feature that would analyze chest X-rays and generate preliminary reports for more than 100 findings.
By Elise Reuter • June 26, 2026 -
Q&A
BD’s Bilal Muhsin talks AI in connected care
Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.
By Elise Reuter • Updated June 25, 2026 -
Tissium secures up to $68M to back rollout of nerve repair platform
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
By Susan Kelly • June 25, 2026 -
MiniMed launches Abbott-made Instinct glucose sensor in Europe
Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.
By Nick Paul Taylor • June 24, 2026 -
Retrieved from Medtronic on June 23, 2026
Medtronic appoints veteran J&J exec as first CFO of innovation
Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.
By Susan Kelly • June 23, 2026 -
Karl Storz laying off employees in North Carolina amid robotics strategy shift
The cuts come as Karl Storz plans to retire the Asensus brand and the Senhance robot as part of organizational changes.
By Susan Kelly • June 22, 2026 -
4 diabetes tech execs on the future of multi-analyte glucose sensors
Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.
By Elise Reuter • June 22, 2026 -
FDA posts early alert over device used with Impella heart pumps
J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body.
By Nick Paul Taylor • June 22, 2026 -
Zoll receives FDA warning letter over quality concerns
The FDA cited problems with some of Zoll’s ventilators, automated external defibrillators and electrodes.
By Elise Reuter • Updated June 22, 2026 -
Penumbra wins CE mark for Thunderbolt clot removal tech
The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.
By Nick Paul Taylor • June 18, 2026 -
Distalmotion, in US push, adds more robotic gynecology indications
The Swiss robotic surgery company, which is rolling out its Dexter system in the U.S., said the new indications will help ASCs maximize use of the system.
By Susan Kelly • June 17, 2026 -
Retrieved from Hologic on June 17, 2026
FDA warns breast biopsy needle shortage to continue into 2027
The shortage follows Hologic removing certain breast biopsy needles from the market in January.
By Elise Reuter • June 17, 2026 -
Medtech M&A maintains momentum following decade-high 2025: PwC
Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and Danaher’s Masimo acquisition.
By Nick Paul Taylor • June 17, 2026